Alembic Pharmaceuticals gains on reporting stellar Q4 numbers

02 May 2013 Evaluate

Alembic Pharmaceuticals is currently trading at Rs 116.50, up by 2.35 points or 2.06% from its previous closing of Rs 114.15 on the BSE.

The scrip opened at Rs 115.00 and has touched a high and low of Rs 122.00 and Rs 114.65 respectively. So far 305902 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 122.00 on 02-May-2013 and a 52 week low of Rs 47.50 on 04-Jun-2012.

Last one week high and low of the scrip stood at Rs 116.50 and Rs 108.75 respectively. The current market cap of the company is Rs 2186.78 crore.

The promoters holding in the company stood at 74.13% while Institutions and Non-Institutions held 8.84% and 17.03% respectively.

Alembic Pharmaceuticals has reported a surge of 114.92% in its net profit at Rs 43.65 crore in Q4FY13 as compared to net profit of Rs 20.31 crore in the same quarter previous year. Total income from operation of the company rose by 10.44% to Rs 378.08 crore as compared to Rs 342.34 crore in corresponding quarter last year.

For the full year, the company has reported a net profit of Rs 165.25 crore for the year ended March 31, 2013, a surge of 26.98% as compared to Rs 130.14 crore for the year ended March 31, 2012. Total income has increased to Rs 1520.34 crore in FY13 from Rs 1465.41 crore in FY12, up by 3.75%.

Alembic Pharma Share Price

1055.00 4.85 (0.46%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.